Bieche I, Parfait B, Tozlu S, Lidereau Roentgen, Vidaud Meters: Quantitation of androgen receptor gene expression when you look at the sporadic breast tumors from the real-big date RT-PCR: facts one MYC was an AR-regulated gene. Carcinogenesis. 2001, twenty two (9): 1521-1526. /carcin/22.9.1521.

Bratthauer GL, Lininger RA, Son YG, Tavassoli FA: Androgen and you may the hormone estrogen receptor mRNA standing inside apocrine carcinomas. Diagn Mol Pathol. 2002, 11 (2): 113-118. 9606-200206000-00008.

Gatalica Z: Immunohistochemical analysis of apocrine breast lesions. Uniform more-phrase off androgen receptor followed closely by the loss of estrogen and progesterone receptors from inside the apocrine metaplasia and apocrine carcinoma inside the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.

In the morning J Clin Pathol

Soreide JA, Lea OA, Varhaug JE, Skarstein Good, Kvinnsland S: Androgen receptors within the operable breast cancer: regards to almost every other steroid hormones receptors, correlations so you can prognostic affairs and you will predictive really worth for aftereffect of adjuvant tamoxifen procedures. Eur J Surg Oncol. 1992, 18 (2): 112-118.

Bayer-Garner IB, Smoller B: Androgen receptors: a marker to increase sensitiveness getting pinpointing breast cancer in facial skin metastasis off not familiar pri, thirteen (2): 119-122. /modpathol.3880021.

Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic craft and you may systematic ramifications. J Clin Oncol. 2000, 18 (5): 1135-1149.

Pang ST, Flores-Morales A great, Skoog L, Chuan YC, Nordstedt G, Pousette An effective: Regulation out of matrix metalloproteinase 13 expression from the androgen within the prostate disease. Oncol Agent. 2004, eleven (6): 1187-1192.

Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer. 1984, 54 (11): 2436-2440. -0142(19841201)<2436::AID-CNCR2820541121>3.0.

Schippinger W, Regitnig P, Dandachi Letter, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F: Analysis of the prognostic importance of androgen receptor expression within the metastatic cancer of the breast. Virchows Arc. 2006, 449 (1): 24-29. /s00428-006-0213-6.

Parker RL, Hunter DG, Lesack DW, Cupples JB, Offer DR, Akbari Meters, Gilks CB: Research of interlaboratory version on immunohistochemical determination of estrogen receptor status playing with a breast cancer tissues microarray. 2002, 117 (5): 723-728. /PEF8-GL6F-YWMC-AG56.

Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, , Garcia-Muniz JL: Study of matrix metalloproteinases as well as their inhibitors into the cancer of the breast. Br J Disease. 2007, 96 (6): 903-911. /sj.bjc.6603666.

Narita D, Raica M, Suciu C, Cimpean A good, Anghel A: Immunohistochemical term out of androgen receptor and prostate-specific antigen in the cancer of the breast. Folia Histochem Cytobiol. 2006, 44 (3): 165-172.

Egeblad Yards, Werb Z: Brand new qualities towards the matrix metalloproteinases when you look at the malignant tumors development. Nat Rev Cancer. 2002, dos (3): 161-174. /nrc745.

Turk V, Kos J, Turk B: Cysteine cathepsins (proteases)–for the main phase regarding cancer tumors?. Cancer Cellphone. 2004, 5 (5): 409-410. /S1535-6108(04)00117-5.

Manes S, Llorente Yards, Lacalle RA, Gomez-Mouton C, Kremer L, Mira E, Martinez Air-conditioning: New matrix metalloproteinase-9 controls the insulin-such as for example increases factor-brought about autocrine reaction when you look at the DU-145 carcinoma cells. J Biol Chem. 1999, 274 (11): 6935-6945. /jbc..

Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel Meters: Release of an invasion promoter E-cadherin fragment by the matrilysin and you can stromelysin-step 1. J Telephone Sci. 2001, 114 (Pt step 1): 111-118.

Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] expression selects having cells with just minimal sensitivity to help you apoptosis. Neoplasia. 2001, step three (6): 459-468. /sj.neo.7900190.

CO;2-H

Stetler-Stevenson WG: Matrix metalloproteinases for the angiogenesis: a moving target to have therapeutic intervention. J Clin Dedicate. 1999, 103 (9): 1237-1241. /JCI6870.

Cornelius La, Nehring LC, Harding E, Bolanowski Yards, Welgus HG, Kobayashi DK, Pierce RA, Shapiro SD: Matrix metalloproteinases generate angiostatin: consequences to the neovascularization. J Immunol. 1998, 161 (12): 6845-6852.

Jiang Y, Goldberg ID, Shi YE: Cutting-edge roles away from cells inhibitors off metalloproteinases inside the cancer tumors. Oncogene. 2002, 21 (14): 2245-2252. /sj.onc.1205291.